Outbreak spotlights safety of custom-mixed drugs

by Marilynn Marchione

Custom-mixed medicines like the steroid shots suspected in a meningitis outbreak have long been a source of concern, and their use is far wider than many people realize.

These medicines are made in private and hospital pharmacies and used to treat everything from cancer to menopause symptoms to .

Often these products are name-brand medicines split into smaller doses, or mixed from ingredients sold in bulk. That can easily lead to contamination if aren't maintained. The germ suspected in the current outbreak can spread in the air.

A shortage of many drugs has forced doctors to stretch supplies and seek custom-made alternatives if the first-choice treatment was not available.

The meningitis outbreak has killed four and sickened at least two dozen in five states.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

User comments